Search - tctmd.com

Displaying 21 - 40 of 160

Sort: Relevancy | Date

News Daily News

DETECT: No Long-term Harm From Paclitaxel Devices in PAD

L.A. McKeown

March 25, 2024

News Conference News CRT 2024

CLIPPER: Emphasis on Faster Revascularization Could Change CLTI Care

L.A. McKeown

March 20, 2024

News Conference News ISET 2024

How to Reconcile BEST-CLI and BASIL-2? A ‘Patient-First’ Strategy

Caitlin E. Cox

January 24, 2024

News Daily News

Top Endovascular News of 2023

L.A. McKeown

December 28, 2023

News Conference News TCT 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

L.A. McKeown

October 25, 2023

News Daily News

AHA Scientific Statement Urges Incorporation of Mental Health Care in PAD

L.A. McKeown

October 06, 2023

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Daily News

FDA Approves Blood Flow-Diverting LimFlow System for No-Option CLTI

L.A. McKeown

September 12, 2023

News Opinion CV Team Dispatch

September 2023 News Roundup

L.A. McKeown

September 01, 2023

News Daily News

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

L.A. McKeown

July 11, 2023

News Conference News LINC 2023

PROSPECT MONSTER: Real-World Data Confirm Low-Dose DCB Efficacy in PAD

L.A. McKeown

June 21, 2023

News Conference News LINC 2023

What Works, What’s Noise? Novel Approaches Offer Hope in CLTI

L.A. McKeown

June 07, 2023

News Conference News SCAI 2023

CLIPPER Attempts to Draw Out Useful Quality Metrics for CLTI

L.A. McKeown

May 25, 2023

News Conference News SCAI 2023

Real-World CLTI Patients, Outcomes Are a Departure From BEST-CLI

L.A. McKeown

May 24, 2023

News Daily News

PROMISE II: Flow-Diverting Procedure May Save Limbs in CLTI

L.A. McKeown

March 29, 2023

News Daily News

Only Half of Revascularized PAD Patients Receive GDMT

L.A. McKeown

February 14, 2023

News Daily News

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

L.A. McKeown

January 24, 2023

News Features

Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI?

L.A. McKeown

December 02, 2022

News Conference News

Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices

L.A. McKeown

November 18, 2022

News Conference News AHA 2022

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

L.A. McKeown

November 07, 2022

Advertisement

DETECT: No Long-term Harm From Paclitaxel Devices in PAD

CLIPPER: Emphasis on Faster Revascularization Could Change CLTI Care

How to Reconcile BEST-CLI and BASIL-2? A ‘Patient-First’ Strategy

Top Endovascular News of 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

AHA Scientific Statement Urges Incorporation of Mental Health Care in PAD

October 2023 News Roundup

FDA Approves Blood Flow-Diverting LimFlow System for No-Option CLTI

September 2023 News Roundup

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

PROSPECT MONSTER: Real-World Data Confirm Low-Dose DCB Efficacy in PAD

What Works, What’s Noise? Novel Approaches Offer Hope in CLTI

CLIPPER Attempts to Draw Out Useful Quality Metrics for CLTI

Real-World CLTI Patients, Outcomes Are a Departure From BEST-CLI

PROMISE II: Flow-Diverting Procedure May Save Limbs in CLTI

Only Half of Revascularized PAD Patients Receive GDMT

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI?

Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content